Mihon, M.I., Pamfil, C., Beyer, R., Tomoaia, R., Gherasim, A.R., Deac, A., Zdrenghea, M.T., Poltorac, V.-I., Fodor, D.M., Mariș, A., Damian, L.O. and Rednic, S. 2025. Pembrolizumab-induced fulminant triple M syndrome presenting with severe bradycardia. Medicine and Pharmacy Reports. (Aug. 2025). DOI:https://doi.org/10.15386/mpr-2834.